1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mainz BioMed NV (MYNZ)
  7. News

MYNZ

Mainz BioMed NV
6.59
-0.01 (-0.15%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Mainz BioMed NV MYNZ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.01 -0.15% 6.59 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.46 5.84 6.55 6.11 6.60
more quote information »

Recent News

Date Time Source Heading
3/15/202303:01GLOBEMainz Biomed Announces Partnership with Labor Staber to..
3/08/202303:01GLOBEMainz Biomed Launches Number of Educational Events in..
3/01/202303:01GLOBEMainz Biomed Recognizes Colorectal Cancer Awareness Month..
2/28/202308:01GLOBEMainz Biomed to Appear on ClearThink IR’s Virtual Live Event..
2/21/202308:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/21/202303:01GLOBEMainz Biomed Acquires Entire Intellectual Property Portfolio..
2/15/202303:01GLOBEMainz Biomed Expands European Commercial Footprint and..
1/20/202316:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/18/202303:01GLOBEMainz Biomed Launches Corporate Health Program in Germany..
1/10/202317:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/09/202306:02EDGARNotice of Effectiveness (effect)
1/03/202303:01GLOBEMainz Biomed Provides Year-End 2022 Corporate Review
12/30/202217:01EDGARSecurities Registration (foreign Private Issuer) (f-3)
12/20/202216:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/20/202203:01GLOBEMainz Biomed Enrolls First Patient in eAArly DETECT Study..
12/07/202206:25TRMNH.C. Wainwright Sticks to Its Buy Rating for Mainz Biomed..
12/06/202208:26TRMNMainz Biomed Soars after IRB Approval for Clinical Study
12/06/202203:01GLOBEMainz Biomed Announces IRB Approval and Initiation of US..
11/29/202208:00GLOBEMainz Biomed Appoints Amy Levin as Vice President of..
11/22/202208:00GLOBEMainz Biomed to Participate in Deutsche Eigenkapitalforum..
11/15/202208:00GLOBEMainz Biomed Announces U.S. Extension of ColoFuture Study to..
11/04/202216:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202211:15TRMNH.C. Wainwright Remains a Buy on Mainz Biomed B.V. (MYNZ)
11/02/202208:00GLOBEMainz Biomed Provides Third Quarter 2022 Update
9/28/202207:00GLOBEMainz Biomed Strengthens Board of Directors with Nomination..
9/20/202203:01GLOBEMainz Biomed Appoints Dr. Douglas Rex to its Medical..
9/08/202206:15TRMNH.C. Wainwright Sticks to Its Buy Rating for Mainz Biomed..
9/07/202206:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/07/202203:01GLOBEMainz Biomed Reports First Half 2022 Financial Results
9/01/202203:01GLOBEMainz Biomed to Present at the H.C. Wainwright Annual Global..
8/23/202203:01GLOBEMainz Biomed Appoints Dr. D. Kim Turgeon of University of..
8/17/202206:25TRMNH.C. Wainwright Sticks to Its Buy Rating for Mainz Biomed..
8/16/202203:01GLOBEMainz Biomed and Dante Genomics Announce Full Commercial..
8/03/202203:01GLOBEMainz Biomed Appoints Former QIAGEN Executive Dr. Frank..
7/19/202203:01GLOBEMainz Biomed Appoints Dr. Timothy Wang to Newly Formed..
7/12/202203:01GLOBEMainz Biomed Today to Provide Corporate Update for First..
7/05/202203:01GLOBEMainz Biomed Provides Corporate Update for First Half of..
6/28/202203:01GLOBEMainz Biomed Enrolls First Patient in ColoFuture Study..
6/14/202203:01GLOBEMainz Biomed Appoints Vice President of Clinical Affairs to..
6/03/202216:56EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/01/202203:01GLOBEMainz Biomed Successfully Completes Conformity Assessment to..
5/19/202203:01GLOBEMainz Biomed & Dante Labs Announce Partnership for the..
5/17/202203:01GLOBEMainz Biomed to Participate in H.C. Wainwright Global..
5/16/202218:24EDGARStatement of Ownership (sc 13g)
5/09/202208:01GLOBEMainz Biomed to Host Key Opinion Leader Event at DDW 2022
5/05/202203:01GLOBEMainz Biomed Provides Product Development Update on..
4/26/202203:01GLOBEMainz Biomed Appoints Darin Leigh as Chief Commercial..
4/12/202203:01GLOBEMainz Biomed Announces First Quarter 2022 Results
3/31/202206:53SEEKMainz Biomed stock rises 10% as it plans reimbursement..
3/31/202203:01GLOBEMainz Biomed Completes Successful Pre-Submission Process..
Your Recent History
NASDAQ
MYNZ
Mainz BioM..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230321 06:18:14